Cell signalling associated with fibrinolytic ligand binding to human colorectal carcinoma cells
- PMID: 1648562
- PMCID: PMC12200249
- DOI: 10.1007/BF01630715
Cell signalling associated with fibrinolytic ligand binding to human colorectal carcinoma cells
Abstract
Addition of purified plasmin or plasminogen (0.1 microM) to serum-free culture media elevated cellular D-myo-inositol 1,4,5-trisphosphate (InsP3) levels in human colorectal carcinoma cells within 1 h to double those of control cells. This was accompanied by decreases in cellular phosphatidylinositol bisphosphate by 40% in cells exposed to fibrinolytic ligands for up to 1 h. The effect was not due to opening of Ca2+ channels of the type blocked by 5 microM nifedipine, and 100 microM EGTA, a Ca2+ chelator, did not suppress plasmin's ability to elevate InsP3. Binding assays at 4 degrees C with 125I-labelled plasmin indicated maximum binding within 1 h suggesting that the effects of plasmin may be associated with its cell-binding function. These cells could convert exogenous plasminogen to plasmin with endogenous activation and this was accompanied by a decrease in radioactive phosphatidylinositol well below control levels (13% of control). Our results contribute to evidence for the association of plasmin-binding sites with a signalling system. A cell signalling system indirectly or directly associated with plasmin binding, would permit carcinoma cells to coordinate extracellular fibrinolysis with cell migration and motility through second messengers.
Similar articles
-
Chondroitin sulfate proteoglycan 4 increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying transforming growth factor-β signalling.Br J Dermatol. 2024 Dec 23;192(1):104-117. doi: 10.1093/bjd/ljae295. Br J Dermatol. 2024. PMID: 39018437 Free PMC article.
-
Thrombolysis for acute ischaemic stroke.Cochrane Database Syst Rev. 2003;(3):CD000213. doi: 10.1002/14651858.CD000213. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2009 Oct 07;(4):CD000213. doi: 10.1002/14651858.CD000213.pub2. PMID: 12917889 Updated.
-
Fibrinolytic activity in infants undergoing cardiac surgery on cardiopulmonary bypass with routine tranexamic acid: A prospective cohort substudy within the FIBrinogen CONcentrate randomised control trial.Eur J Anaesthesiol. 2025 May 1;42(5):389-397. doi: 10.1097/EJA.0000000000002124. Epub 2025 Jan 31. Eur J Anaesthesiol. 2025. PMID: 39895347 Clinical Trial.
-
Antioxidants for female subfertility.Cochrane Database Syst Rev. 2013 Aug 5;(8):CD007807. doi: 10.1002/14651858.CD007807.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2017 Jul 28;7:CD007807. doi: 10.1002/14651858.CD007807.pub3. PMID: 23913583 Updated.
-
Neutrophil-Mediated Inflammatory Plasminogen Degradation, Rather Than High Plasminogen-Activator Inhibitor-1, May Underly Failures and Inefficiencies of Intrapleural Fibrinolysis.Chest. 2025 Jan;167(1):67-75. doi: 10.1016/j.chest.2024.04.005. Epub 2024 May 6. Chest. 2025. PMID: 38710463 Clinical Trial.
References
-
- Ambler SK, Thompson B, Solski PA, Brown JH, Taylor P (1987) Receptor mediated inositol phosphate formation in relation to calcium mobilization. Mol Pharmacol 32:376–383 - PubMed
-
- Ashkenazi A, Winslow JW, Peralta EG, Peterson GL, Schimerlik MI, Capon DJ, Ramachandran J (1987) An M2 muscarinic receptor subtype coupled to both Adenyl Cyclase and Phosphoinositide turnover. Science 238:672–675 - PubMed
-
- Burt DR (1978) Criteria for receptor identification. In: Yamamura HI, Enna SJ, Kuhar MJ (eds) Neurotransmitter receptor binding. Raven, New York, pp 41–55
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous